Point72 Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
|
|||||
2023
Q3 | $11.3M | Buy |
|
|||||
2023
Q2 | – | Sell |
|
|||||
2023
Q1 | $24M | Sell |
|
|||||
2022
Q4 | $34.1M | Buy |
|
|||||
2022
Q3 | $7.11M | Sell |
|
|||||
2022
Q2 | $7.42M | Buy |
|
|||||
2022
Q1 | – | Sell |
|
|||||
2021
Q4 | $70.4M | Buy |
|
|||||
2021
Q3 | – | Sell |
|
|||||
2021
Q2 | $6.46M | Sell |
|
|||||
2021
Q1 | $45.8M | Buy |
|
|||||
2020
Q4 | $47.3M | Buy |
|
|||||
2020
Q3 | – | Sell |
|
|||||
2020
Q2 | $21.3M | Buy |
|
|||||
2019
Q4 | – | Sell |
|
|||||
2019
Q3 | $46.4M | Buy |
|
|||||
2019
Q2 | $42.1M | Buy |
|
|||||
2019
Q1 | $1.26M | Buy |
|
|||||
2018
Q4 | – | Sell |
|
|||||
2018
Q3 | $730K | Buy |
|
|||||
2018
Q2 | – | Sell |
|
|||||
2018
Q1 | $12.5M | Buy |
|
|||||
2017
Q4 | $1.48M | Buy |
|